Morningstar will cease full analyst coverage of Harding Loevner Global Equity (which includes a US mutual fund, a US separately managed account, and a European cross-border mutual fund) on or around July 26, 2024, so our analysts can spend more time researching other strategies. In the future, this strategy will receive an algorithmically assigned Morningstar Medalist Rating. Users should form their own views on this strategy or obtain financial advice.
Harding Loevner Global Equity Inst HLMVX
- NAV / 1-Day Return 41.94 / −0.07 %
- Total Assets 1.0 Bil
-
Adj. Expense Ratio
0.900%
- Expense Ratio 0.900%
- Distribution Fee Level Average
- Share Class Type Institutional
- Category Global Large-Stock Growth
- Investment Style Large Growth
- Min. Initial Investment 100,000
- Status Open
- TTM Yield 0.31%
- Turnover 28%
USD | NAV as of May 23, 2024 | 1-Day Return as of May 23, 2024, 11:59 PM GMT+0
Morningstar’s Analysis HLMVX
Will HLMVX outperform in future?
Get our overall rating based on a fundamental assessment of the pillars below.
People Pillar
Parent Pillar
- Current Portfolio Date
- Equity Holdings —
- Bond Holdings —
- Other Holdings —
- % Assets in Top 10 Holdings 35.9
|
Top 10 Holdings
|
% Portfolio Weight
|
Market Value USD
|
Sector
|
|---|---|---|---|
Microsoft Corp | 4.70 | 48.0 Mil | Technology |
Meta Platforms Inc Class A | 4.59 | 46.9 Mil | Communication Services |
Schneider Electric SE | 4.56 | 46.6 Mil | Industrials |
Vertex Pharmaceuticals Inc | 3.99 | 40.8 Mil | Healthcare |
Alphabet Inc Class A | 3.96 | 40.5 Mil | Communication Services |
Amazon.com Inc | 3.84 | 39.3 Mil | Consumer Cyclical |
Thermo Fisher Scientific Inc | 2.75 | 28.1 Mil | Healthcare |
Netflix Inc | 2.70 | 27.6 Mil | Communication Services |
Deere & Co | 2.55 | 26.1 Mil | Industrials |
Alcon Inc | 2.24 | 22.9 Mil | Healthcare |